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Abstract 
INTRODUCTION: Vici syndrome, a rare autosomal recessive disorder, was first described in 1988 by Vici et al. 
Only 78 cases have been reported to date. The syndrome is characterised by agenesis of the corpus callosum, 
hypopigmentation, cardiomyopathy, progressive failure to thrive, dysmorphic features, immunodeficiency and 
cataracts. Mutations in the gene epg5 have been identified as the cause of Vici syndrome. 
CASE DESCRIPTION: The parents are a consanguineous Saudi couple with two other children diagnosed with 
Gaucher disease. The patient was born at term and in the first 5 months had many hospital admissions for a 
recurrent chest infection. Physical examination, investigations and imaging studies revealed that the patient had 
agenesis of the corpus callosum, cataracts, psychomotor delay, immunodeficiency and hypopigmentation. The 
initial echocardiogram was normal. At 7 months, genetic testing confirmed the diagnosis of Vici syndrome with a 
c.3693G>Ap (Gln1231Gln) mutation in the gene EPG5. The patient developed a chest infection and was admitted 
to the pediatric intensive care unit. An echocardiogram was repeated and showed significant left ventricular 
dilation with a Z-score of 3.1, moderate mitral and tricuspid regurgitation, and depressed ventricular function with 
a fractional shortening of 17% and ejection fraction 37%. The patient’s condition deteriorated, and he died aged 8 
months. 
CONCLUSION: The symptoms of extensive system involvement in Vici syndrome have been present in the 
majority of reported cases and should prompt careful evaluation of this syndrome when such symptoms are 
present in an infant. In confirmed cases, close monitoring of the immune status and cardiac function, the two main 
causes of death among Vici syndrome patients, is vital to prevent rapid deterioration and improve life expectancy. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Vici syndrome (VICIS) (OMIM 242840) is a 
rare autosomal recessive disease belonging to the 
group of congenital disorders of autophagy. The 
syndrome has a wide range of presentations involving 
various body systems [1] [2] and is caused by a 
mutation in epg5, the gene for ectopic P-granules 
protein 5 (EPG5) on chromosome 18 [2]. The EPG5 
protein is responsible for regulating autophagy 
activity, a pivotal mechanism for the development and 
proper functioning of body organs. The first two cases 
were described by Vici and his colleagues in 1988 
when they reported on two siblings with a set of 
clinical features comprising agenesis of the corpus 
callosum, cutaneous hypopigmentation, bilateral 
cataract, cleft lip and palate, and combined 
immunodeficiency [3].  
Since that original description of the disorder, 
an increasing number of cases have been reported, 
with almost 78 confirmed cases published to date [3] 
[4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] 
[18] [19] [20] [21] [22]. The patients have presented, 
mostly in infancy, with characteristic features of VICIS 
together with other phenotypic features such as 
progressive failure to thrive, microcephaly, 
nystagmus, dysmorphic features, cardiomyopathy, 
hypotonia, and recurrent pulmonary infection, among 
others [4]. Features such as hearing loss, lung 
hypoplasia, and renal tubular necrosis have also been 
described in isolated cases [6] [7] [8].  
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In this report, which includes a review of all 
literature to date, we describe in detail a previously 
reported case [9]
 
of an 8-month-old male infant 
diagnosed with VICIS. 
 
 
Case Description 
 
We report on a boy, the third child of healthy 
consanguineous first-cousin Saudi parents. His two 
brothers are confirmed cases of Gaucher disease. 
The boy is a product of spontaneous vaginal delivery 
at 36 weeks gestational age with birth weight 3.2 kg. 
At 10 days of age, he was admitted to the neonatal 
intensive care unit because of meconium aspiration 
and group B streptococcus sepsis.  
During the first month of life at home, the 
patient developed poor sucking and choking attacks 
with each feeding. At the age of 2 months, he was 
admitted to an outside hospital as a case of aspiration 
pneumonia and was treated accordingly. Diagnosis of 
gastroesophageal reflux disease was also made, and 
he underwent a fundoplication. During that admission, 
the patient was evaluated for the choking attacks and 
hypotonia. Chromosomal analysis revealed a normal 
karyotype (46XY).  
At 5 months of age he was admitted to our 
hospital, for the first time, as a case of pneumonia. On 
physical examination, he also had profound hypotonia 
and albinism. Abdominal ultrasound was 
unremarkable and ruled out any organomegaly for 
other metabolic syndromes. Visual evoked response 
(VER) was significant for bilateral P100 prolongation 
and abnormal NPN configuration. VICIS was 
suspected as a cause of his multisystem symptoms. 
Magnetic resonance imaging (MRI) of the brain 
showed complete agenesis of corpus callosum, 
hypoplastic pons, and volume loss of white matter 
(Figure 1). Echocardiographic evaluation showed 
normal function with only mild left ventricular 
hypertrophy and fractional shortening of 33.1%. 
Genetic testing identified a pathogenic variant of epg5 
(c.3693G>A p. (Gln1231Gln) and confirmed the 
diagnosis of VICIS. 
 
Figure 1: Brain MRI at age 6 months. Medline sagittal T1 weighted 
sequence (A), showing agenesis of corpus callosum and 
hypoplastic pons. Coronal T1 (B) and axial T2 (C) showing loss of 
white matter and dilated ventricular system 
Following this admission, the patient 
presented several times to our hospital with recurrent 
infections including bronchial pneumonia, urinary tract 
infection and gastroenteritis. At the age of 7 months 
he presented to the emergency department following 
a 3-week episode of bloody diarrhea with severe 
dehydration. On physical examination, the patient 
looked pale, cachectic, not oriented, with sunken eyes 
and anterior fontanelles. His arterial blood gases 
revealed hypokalemia with metabolic acidosis (K = 2 
mmol/L, pH = 7.28, PCO2 = 37 torr, HCO3 = 16.8 
mmol/L). His weight had dropped 2.1 kg from the 
admission a month previously. He was admitted to the 
pediatric intensive care unit for rehydration and 
monitoring. During the course of this admission, the 
immunologic workup revealed reduced absolute B and 
T cell counts; immunoglobulins A, M and G were 
within the normal range. A few days later, the patient 
suddenly became apneic and developed respiratory 
distress. Chest X-ray revealed cardiomegaly. 
Repeated echocardiography showed dilated 
cardiomyopathy. His echocardiogram findings were 
significant for left ventricular dilation with a Z-score of 
3.1, moderate mitral and tricuspid regurgitation, and 
depressed ventricular function with fractional 
shortening of 17% and ejection fraction 37%. He 
deteriorated quickly and developed renal impairment, 
which worsened his electrolyte imbalance and 
metabolic acidosis. Eventually, the patient went into 
cardiopulmonary arrest and died. 
 
 
Discussion 
 
VICIS is a rare disease that affects multiple 
systems of the body. Since the condition was first 
described in 1988, a total of 78 cases —including our 
patient's—have been reported (Table 1). The 
incidence of this disease is yet to be determined. 
VICIS was first linked to a recessive mutation in EPG5 
in 2013 [1]. The EPG5 protein is responsible for 
regulating autophagy activity, which is a survivor-cell 
mechanism that selectively removes misfolded 
proteins and organelles and plays a paramount role in 
ensuring good development of body systems, 
especially the nervous system. In our patient, genetic 
testing showed a c.3693G>A p.(Gln1231Gln) mutation 
in epg5, confirming the diagnosis of VICIS.  
Table 2 summarizes all the important features 
that have been associated with VICIS to date. The 
majority of reported cases were associated with 
recurrent infections (98.7%), agenesis of corpus 
callosum (97.4%), profound developmental delay 
(97.4%), skin involvement (96.2%), immunodeficiency 
(76.9%), cataract (62.8%) and cardiomyopathy 
(65.4%) with the hypertrophic type being most 
commonly reported. We suggest, therefore, that VICIS 
should be considered to head the list of differential 
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diagnoses for an infant who presents with all or most 
of these features. 
Table 1: Summary of reported patients with Vici syndrome 
Authors, year Sex Age (m) Clinical outcome 
Vici et al., 1988 [3] M 24 Deceased 
M 36 
Del Campo et al., 1999 [4] M 24 Deceased 
F 11 Deceased 
M 36 Alive 
F 16 Deceased 
Chiyonobu et al., 2002 [5] F 19 Deceased 
M 6 Alive 
Miyata et al., 2007 [6] F 12 Deceased 
M 11 Alive 
McClelland et al., 2010 [7] M 3 Deceased 
Al-Owain et al., 2010 [8] M 9 Deceased 
Rogers et al., 2011 [10] M 96 Deceased 
F 96 Deceased 
Said et al., 2012 [11] F 15 Deceased 
Finocchi et al., 2012 [12] M 24 Alive 
Özkale et al., 2012 [13] F 6 Deceased 
Cullup et al., 2013 [1] F 15 Deceased 
M 3 Alive 
M 48 Alive 
M 36 Alive 
M 9 Alive 
M 36 Alive 
M 24 Alive 
M 24 Alive 
F 120 Alive 
Ehmke et al., 2014 [14] M 3.5 Deceased 
Filloux et al., 2014 [15] F 17 Alive 
Tasdemir et al., 2015 [16] M 9 Deceased 
M 8 
El-Kersh et al., 2015 [17] F 72 Deceased 
Byrne et al., 2016 [2] NS NS NS 
Huenerberg et al., 2016 [18] 
 
F 11 Deceased 
F 13 
Maillard et al., 2017 [19] 
 
F 24 Alive 
Hori et al., 2017 [20] 
F 84 Alive 
F 24 Alive 
F 180 Alive 
F 12 Deceased 
F 48 Alive 
F 24 Alive 
M 168 Deceased 
M 60 Alive 
M 84 Alive 
Hedberg-Oldfors et al., 2017 [21] M 8 Deceased 
Elsayed et al., 2018 [22] M 7 Deceased 
This Case M 8 Deceased 
M = male; F = female; NS = not specified; m months. 
 
Our findings support those published in a 
review of 38 cases [2] of VICIS where agenesis of 
corpus callosum, profound developmental delay and 
immune problems were the most common shared 
features. 
Table 2: Common clinical features of 78 cases of Vici 
syndrome 
Feature Positive Negative Not 
reported 
n (%) 
Recurrent infections 77 - 1 77/78 (98.7) 
Corpus callosum agenesis 76 - 2 76/78 (97.4) 
Profound developmental delay 76 1 1 76/78 (97.4) 
Cutaneous manifestations 75 3 - 75/78 (96.2) 
Immune system involvement 60 16 2 60/78 (76.9) 
Cardiomyopathy 51 18 9 51/78 (65.4) 
Cataract 49 25 4 49/78 (62.8) 
Microcephaly 45 15 18 45/78 (57.7) 
Hypotonia 37 - 41 37/78 (47.4) 
Seizures 26 16 36 26/78 (33.3) 
Growth retardation 24 - 54 24/78 (30.8) 
 
Concurrently with the clinical assessment, 
there are multiple investigations to help shorten the 
list of differential diagnoses and assess the extent of 
organ involvement [23] [24]. Such tests include 
laboratory investigation, imaging, molecular and other 
tests. Laboratory investigations will be directed to 
assess immunodeficiency and the extent of 
involvement of other organs such as liver and kidneys.  
For imaging, a brain MRI is essential for 
detection of agenesis of corpus callosum and other 
less specific neuroradiologic abnormalities that have 
been reported, such as vermis and pons hypoplasia. 
Chest X-ray and echocardiography are also of benefit 
for assessing lung and cardiac involvement, 
respectively. Abdominal ultrasonography helps to 
confirm laboratory findings, whether abdominal organs 
are affected or not.  
Confirmation of diagnosis requires molecular 
genetic testing to identify the homogenous or 
compound heterogenous mutated epg5. Other useful 
tests for VICIS cases are ophthalmologic tests and 
electroencephalography (EEG), especially if seizures 
are present. Our patient underwent all these 
investigations apart from the EEG, as seizures were 
absent; this helped to confirm the diagnosis and 
identify the present complications, thus allowing us to 
tailor our interventions.  
VICIS is a progressive disease with poor 
prognosis. Survival analysis shows that VICIS patients 
have a median survival time of 24 months (95% 
confidence interval, 0–39 months) [2]. Thus, 
therapeutic interventions for VICIS are merely 
supportive and directed to relieve the symptoms that 
result from multi-organ involvement and to improve 
the survival time.  
The most common causes of death among all 
reported patients with VICIS are recurrent infections 
and cardiomyopathy. Cardiac functions, in particular, 
can deteriorate from baseline in a short time, as 
happened in our patient. Immunity status and cardiac 
function, therefore, need to be regularly monitored at 
short intervals for early detection of their VICIS-related 
manifestations, thus allowing timely intervention for a 
better outcome and prolonged survival. 
In conclusion, in VICIS, the symptoms of 
extensive system involvement (such as agenesis of 
corpus callosum, profound developmental delay, 
recurrent infections and immunodeficiency) that 
present in the majority of cases should prompt a 
careful evaluation for this syndrome. When the 
diagnosis is confirmed, close monitoring of the 
immune status and cardiac function is vital to prevent 
rapid deterioration and improve life expectancy, as 
these have been the two main causes of death among 
VICIS patients in all known cases to date.  
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